Clinical Trials Logo
  1. Home
  2. Neuropathic Pain
  3. NCT02666456
  4. Details
NCT02666456 Clinical Trial

The Influence of Sensory Phenotype on the Risk of Developing Neuropathic Pain

Neuropathic Pain Clinical Trial

Official title:
DOLORisk: Understanding Risk Factors and Determinants for Neuropathic Pain - The Influence of Sensory Phenotype on the Risk of Developing Neuropathic Pain

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT02666456
Other study ID # DOLORisk WP4
Secondary ID
Status Not yet recruiting
Phase N/A
First received January 11, 2016
Last updated January 25, 2016
Start date April 2016

Study information
Verified date January 2016
Source University of Kiel
Contact Andreas Binder, MD
Phone +49 431 597
Email andreas.binder@uksh.de
Is FDA regulated No
Health authority Germany: Ethic committee Kiel
Study type Observational

Clinical Trial Summary

Cross-sectional and longitudinal analysis of the somatosensory phenotype, assessed by quantitative sensory testing (QST) and Information obtained by questionnaires to detect risk factors for neuropathic pain development and chronification in painless and chronic pain patients.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 1500
Est. completion date
Est. primary completion date March 2019
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Chronic peripheral neuropathic pain or

- Painless Patient with risk to develop neuropathic pain (post-surgery, chemotherapy-induced)

Exclusion Criteria:

- Minors

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Intervention

Other:
• QST, Questionnaires
Assessment of sensory phenotype by QST and questionnaires

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
University of Kiel

Outcome
Type Measure Description Time frame Safety issue
Primary Somatosensory phenotype detected by quantitative sensory testing (QST) The somatosensory phenotype will be assessed by quantitative sensory testing (QST) once at baseline Single assessment at baseline (cross-sectional study). Report of complete cohort data at study completion No
Primary Change of neuropathic pain: Development and chronification of neuropathic pain detected by DN4 questionnaire Assessment with DN4 pain questionnaire Assessment of change of neuropathic pain from baseline and 6 months after study enrollment (longitudinal study). Report of complete cohort data at study completion. No
See also
  Status Clinical Trial Phase
Recruiting NCT04699734 - Peripheral Nerve Block in Patients With Painful Diabetic Polyneuropathy N/A
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Completed NCT05235191 - Effectiveness and Safety of Methadone Versus Placebo for the Control of Neuropathic Pain in Different Etiologies Phase 3
Completed NCT05845177 - Persistent Pain After Hip Replacement
Not yet recruiting NCT05949554 - Electroencephalographic (EEG) Profils for Patients on Intravenous Ketamine.
Withdrawn NCT05052645 - Ear Acupuncture for Neuropathic Pain N/A
Completed NCT02824588 - Working Memory Training for Chronic Neuropathic and Fibromyalgia Pain N/A
Completed NCT02930551 - Neuromas as the Cause of Pain N/A
Completed NCT02866396 - Impact of Pregabalin in Chronic Users vs. a Perioperative Limited Prescription on Oxycodone Requirement
Active, not recruiting NCT02560545 - Cannabinoids Effects on the Pain Modulation System N/A
Enrolling by invitation NCT02485795 - Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management N/A
Not yet recruiting NCT02246517 - The Effect of N2O on Chronic Neuropathic Pain Patients Phase 0
Completed NCT02099890 - The Effect of Diet on Chronic Inflammation and Related Disorders Following Spinal Cord Injury Phase 3
Completed NCT01946555 - Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain N/A
Completed NCT01718821 - Assessments on Current Pain Managements in Upper Gastrointestinal Cancer Patients N/A
Completed NCT01884662 - Virtual Walking for Neuropathic Pain in Spinal Cord Injury N/A
Completed NCT01669967 - The Role of Intravenous (IV) Lidocaine in the Management of Chronic Neuropathic Pain of Peripheral Nerve Origin N/A
Completed NCT01207596 - Evaluating the Efficacy and Safety of Extended Release Hydromorphone (Exalgo) in Patients With Neuropathic Pain Phase 4
Completed NCT01201317 - A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Painful Diabetic Polyneuropathy Phase 2
Active, not recruiting NCT00996983 - Safety and Activity Study of Intrathecally Administered Ziconotide for Neuropathic Pain in Patients With Cancer Phase 2

External Links